{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Morepen Laboratories Ltd
Why is Morepen Labs. falling/rising?
As of 24-Nov, Morepen Laboratories Ltd has experienced a notable decline in its share price, reflecting ongoing challenges in its financial performance and market positioning. The stock closed at ₹43.10, down by ₹0.91 or 2.07%, continuing a downward trend that has persisted over the past week.
How has been the historical performance of Morepen Labs.?
Morepen Labs has shown consistent growth in net sales and profitability, with net sales increasing from 768.54 crore in March 2019 to 1,811.58 crore in March 2025, and profit after tax rising from 28.84 crore to 118.02 crore in the same period. The company's total assets and liabilities also grew significantly, reflecting robust expansion.
Is Morepen Labs. technically bullish or bearish?
As of November 19, 2025, Morepen Labs is in a bearish trend with moderate strength, supported by bearish MACD and moving averages, while showing mixed signals from KST and underperforming against the Sensex.
Morepen Laboratories Technical Momentum Shifts Amid Bearish Indicators
Morepen Laboratories has experienced a notable shift in its technical momentum, with recent evaluation adjustments reflecting a predominantly bearish outlook across key indicators. This article analyses the current technical signals, price movements, and comparative returns to provide a comprehensive view of the stock’s market position within the Pharmaceuticals & Biotechnology sector.
Why is Morepen Labs. falling/rising?
As of 19-Nov, Morepen Laboratories Ltd's stock price is declining at 45.52, down 0.48%, and has underperformed its sector. The stock has fallen 3.44% over the last five days and has a year-to-date decline of 41.86%, reflecting negative investor sentiment due to poor financial performance and lack of confidence from domestic mutual funds.
Is Morepen Labs. overvalued or undervalued?
As of November 17, 2025, Morepen Labs is fairly valued with a PE ratio of 33.58, lower than Sun Pharma's 36.69 but higher than Cipla's 22.81, and has a low PEG ratio of 0.00, while underperforming the Sensex with a stock return of -38.87%.
Morepen Laboratories Faces Mixed Technical Trends Amid Market Challenges
Morepen Laboratories, a small-cap pharmaceutical company, is currently facing market challenges, reflected in its recent stock price and year-to-date performance. Despite a positive three-year return, its five-year performance lags behind the Sensex. Technical indicators present a mixed outlook, suggesting potential volatility ahead.
Morepen Laboratories Q2 FY26: Profit Surge Masks Underlying Margin Pressures
Morepen Laboratories Ltd. delivered a dramatic turnaround in Q2 FY26, posting consolidated net profit of ₹40.87 crores—a staggering 280.19% surge quarter-on-quarter from ₹10.75 crores in Q1 FY26. However, the pharmaceutical manufacturer's shares have declined 38.87% over the past year, trading at ₹46.23 as of November 17, 2025, reflecting persistent investor concerns about margin compression and operational headwinds despite the quarterly profit rebound.
How has been the historical performance of Morepen Labs.?
Morepen Labs has shown consistent growth, with net sales rising from 768.54 crore in March 2019 to 1,811.58 crore in March 2025, and profit after tax increasing from 28.84 crore to 118.02 crore during the same period, indicating strong financial performance and asset growth.
Is Morepen Labs. technically bullish or bearish?
As of November 13, 2025, Morepen Labs is in a bearish trend with moderate strength, driven by bearish MACD, moving averages, and Bollinger Bands, despite some mixed signals from the KST and Dow Theory.
Morepen Laboratories Faces Bearish Technical Trends Amidst Market Challenges
Morepen Laboratories, a small-cap pharmaceutical company, has faced significant challenges, reflected in its year-to-date return of -40.46%. Despite recent bearish technical indicators, the company has shown resilience over three- and five-year periods, with returns of 63.58% and 66.20%, respectively, although still trailing the Sensex.
Is Morepen Labs. technically bullish or bearish?
As of November 12, 2025, Morepen Labs exhibits a weak bearish trend, with key indicators like the MACD and Bollinger Bands signaling bearish momentum, despite some mild bullishness from the KST.
Morepen Laboratories Faces Mixed Technical Trends Amid Market Evaluation Revision
Morepen Laboratories, a small-cap pharmaceutical company, has experienced a significant decline of 41.07% over the past year, contrasting with the Sensex's positive return. Despite mixed technical indicators and recent price fluctuations, the company has shown resilience with strong long-term performance over three and five years.
How has been the historical performance of Morepen Labs.?
Morepen Labs has shown consistent growth in net sales and profitability, with net sales increasing from 768.54 crore in March 2019 to 1,811.58 crore in March 2025, and profit after tax rising from 28.84 crore to 118.02 crore during the same period. The company's total assets and liabilities also grew significantly, reflecting its expansion strategy.
Morepen Laboratories Faces Evaluation Adjustment Amid Declining Sales and Profit Metrics
Morepen Laboratories has undergone a recent evaluation score adjustment, reflecting challenges in its financial performance. The company reported an 8.72% decline in net sales, alongside significant reductions in Profit Before Tax and Profit After Tax. These trends indicate ongoing difficulties in the current market environment.
Is Morepen Labs. technically bullish or bearish?
As of November 6, 2025, Morepen Labs is in a bearish trend with moderate strength, indicated by a bearish MACD, bearish Bollinger Bands, and underperformance against the Sensex, despite a mildly bullish KST on the weekly chart.
Morepen Laboratories Faces Bearish Technical Trends Amidst Market Challenges
Morepen Laboratories, a small-cap pharmaceutical company, has experienced a challenging year with a significant stock decline, contrasting with the Sensex's performance. Technical indicators suggest a bearish sentiment, although the company has shown resilience over longer periods, outperforming the Sensex in three- and five-year returns.
Morepen Laboratories Faces Performance Challenges Amid Shift to Mildly Bearish Outlook
Morepen Laboratories has recently experienced a change in evaluation, indicating a shift in its technical outlook. The company has faced challenges, including declining net sales and consecutive quarters of negative results. Despite a low debt-to-equity ratio and attractive valuation, it has significantly underperformed the broader market.
Is Morepen Labs. technically bullish or bearish?
As of November 3, 2025, Morepen Labs exhibits a mildly bearish trend due to bearish momentum from the weekly MACD and Bollinger Bands, despite some bullish strength indicated by the weekly RSI.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
